Mark Jones, PhD, Head of Project Management at Basilea Pharmaceutica joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘navigating regulatory perspectives ‘.
In this presentation, learn about navigating regulatory perspectives in the context of the unmet medical need for new antifungals .
Download the presentation to understand more about:
- Where will our new antifungals come from?
- The net present value (NPV) of a typical antimicrobial
- Incentives for making drug development more attractive
…and much more!
Get your copy here!
To learn more about regulatory perspectives and unmet medical needs for new antimicrobials , join us at World Anti-Microbial Resistance Congress USA 2016 held September 8-9 in Washington, DC.